Sullivan et al., 1983 - Google Patents
X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency.Sullivan et al., 1983
View PDF- Document ID
- 9200486679203767139
- Author
- Sullivan J
- Byron K
- Brewster F
- Baker S
- Ochs H
- et al.
- Publication year
- Publication venue
- The Journal of clinical investigation
External Links
Snippet
The X-linked lymphoproliferative syndrome is characterized by immunodeficiency to Epstein- Barr virus (EBV) manifested by severe or fatal infectious mononucleosis and acquired immunodeficiency. We studied immune responses in six males of a well-characterized …
- 206010068348 X-linked lymphoproliferative syndrome 0 title abstract description 11
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sullivan et al. | X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency. | |
| Usuku et al. | HLA haplotype‐linked high immune responsiveness against HTLV‐I in HTLV‐I‐associated myelopathy: comparison with adult T‐cell leukemia/lymphoma | |
| DAVIS et al. | Acquired immunodeficiency syndrome in a patient with hemophilia | |
| Herzig et al. | Correction of poor platelet transfusion responses with leukocyte-poor HL-A-matched platelet concentrates | |
| Gerber et al. | Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures | |
| CHEESEMAN et al. | Epstein-Barr virus infection in renal transplant recipients: effects of antithymocyte globulin and interferon | |
| Meyers et al. | Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant | |
| Carney et al. | Functional properties of T lymphocytes and their subsets in cytomegalovirus mononucleosis. | |
| Lalezari et al. | An isologous antigen-antibody reaction with human neutrophiles, related to neonatal neutropenia. | |
| Tevethia et al. | Requirement of thymus-derived θ-positive lymphocytes for rejection of DNA virus (SV40) tumors in mice | |
| de Gast et al. | Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft | |
| Crawford et al. | Studies on long‐term T‐cell‐mediated immunity to epstein‐barr virus in immunosuppressed renal allograft recipients | |
| Mayernik et al. | Differentiation-associated alteration in human monocyte-macrophage accessory cell function. | |
| Santoni et al. | Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. I. Distribution of the reactivity | |
| Bloom et al. | Studies on the interactions between viruses and lymphocytes | |
| Søndergaard et al. | Immune function and phenotype before and after highly active antiretroviral therapy | |
| Bender et al. | Analysis of immune status of hemodialyzed adults: association with prior transfusions | |
| Sullivan et al. | Treatment of life-threatening Epstein-Barr virus infections with acyclovir | |
| Hafler et al. | Phenotypic and functional analysis of T cells cloned directly from the blood and cerebrospinal fluid of patients with multiple sclerosis | |
| Drummond et al. | BK virus specific humoral and cell mediated immunity in allogeneic bone marrow transplant (BMT) recipients | |
| LJUNGMAN et al. | Lymphocyte responses after cytomegalovirus infection in bone marrow transplant recipients—a one-year follow-up | |
| Teute et al. | Replication of herpes simplex virus in human T lymphocytes | |
| Williams et al. | Molecular studies of T-lymphocytes from cattle infected with bovine leukemia virus | |
| SULLIVAN | Epstein-Barr virus and the X-linked lymphoproliferative syndrome | |
| Fleischer et al. | Phenotypic markers and functional characteristics of T lymphocyte clones from cerebrospinal fluid in multiple sclerosis |